As most Texas women who have given birth can likely attest, pregnancy can
be a difficult and draining experience. Particularly during a pregnant
woman’s first trimester, morning sickness and the accompanying nausea
can be severe. Some women may take medication for this condition in order
to keep it under control and go about their daily lives. However, some
medications may carry the threat of adverse effects on developing fetuses.
Studies now show that one popular anti-nausea medication may actually put
unborn babies at risk for birth defects. The drug, Zofran, is known generically
as ondansetron. The drug blocks the action of serotonin and is described
as a 5-HT3 receptor antagonist. A study out of Boston University and Harvard
demonstrates that exposure to Zofran or its generic equivalent can put
women at risk for delivering a child with a cleft palate. In particular,
the study found that women exposed to Zofran or ondansetron were over
twice as likely to deliver a child with this condition.
Researchers from Sweden have also found that Zofran may cause serious injury
when combined with pregnancy. The European researchers reviewed records
from 1998 through 2012 and found that women who used Zofran during the
early part of their pregnancy were over 60 percent more likely to have
a child with a cardiovascular defect.
Birth defects and
birth injuries may be the product of negligence and irresponsibility. Physicians, hospitals,
pharmacists and drug companies all have specific responsibilities that
relate to the safety and health of pregnant women. If a child’s health
problem is the result of another’s negligence, the family may be entitled
to compensation for injuries. A Houston medical malpractice attorney can
help local families understand and initiate their birth injury case.
Source: The National Law Review, “Zofran studies link medication to serious health risks,” June 9, 2015